Catalyst Event
Caris Life Sciences Inc (CAI) · Other
From KEDI U.S. Medical AI Index (KUSMAI)
3/24/2026, 12:00:00 AM
Presented an oral presentation titled 'BCORL1::CREBBP Fusions Characterize an Aggressive Frequently Ossifying Bone and Soft Tissue Sarcoma' at the USCAP 2026 Annual Meeting on March 24, 2026.
Korean Translation
2026년 3월 24일 USCAP 2026 연례 회의에서 '공격적인 골화성 골 및 연조직 육종을 특징짓는 BCORL1::CREBBP 융합'에 대한 구두 발표를 진행함.
Related Recent Events
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA's Q1 2027 earnings release is scheduled for May 20, 2026; Medium importance is assigned as earnings typically drive 5-10% volatility, and analysts forecast an EPS of $1.74-$1.76 estimated.
5/20/2026, 12:00:00 AM
Schrodinger Inc (SDGR) · Earnings Release
First quarter 2026 earnings release scheduled. Analysts forecast an EPS of approximately -$0.56. As a major price catalyst, high importance is expected.
5/6/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
Tempus AI is expected to report its Q1 2026 earnings, with analysts forecasting revenue of approximately $345.40M and a normalized EPS of -$0.19; medium impact expected from quarterly earnings release, scheduled.
5/5/2026, 12:00:00 AM
Hims & Hers Health Inc (HIMS) · Earnings Release
Q1 2026 earnings release and conference call, with low importance estimated due to the routine nature of the announcement, scheduled.
5/5/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Earnings Release
Alphabet's Q1 2026 earnings release is scheduled; major tech earnings typically cause >=5% price impact, justifying a Medium importance estimate.
4/23/2026, 12:00:00 AM
Intuitive Surgical Inc (ISRG) · Earnings Release
Intuitive Surgical's first-quarter 2026 earnings release is scheduled. I estimate Medium importance as earnings reports typically cause significant price movement, so the event is scheduled.
4/21/2026, 12:00:00 AM